ALYVANT
Roivant Sciences GmbH
Application Filed: 2018-07-17
Trademark Application Details
FINAL REFUSAL - MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79255282 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Allison Strickland Ricketts |
| Attorney Docket Number | ROIV 1800910 |
| Law Office Assigned | L80 |
| Employee Name | BURDECKI, ANNA C |
Timeline
| 2018-07-17 | Application Filed |
| 2019-11-09 | Location: TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED |
| 2019-11-09 | Status: Live/Pending |
| 2019-11-09 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Roivant Sciences GmbH |
| Address | Viaduktstrasse 8 CH-4051 Basel CH |
| Legal Entity Type | Gesellschaft Mit Beschränkter Haftung (gmbh) |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0091 | Computer software for providing, analyzing and generating reports; computer software for data processing; software and computer programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; software and computer programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analyzing data in the fields of public health, healthcare, namely pharmaceutical commercialization, biomedical research and software for analyzing clinical trial data; downloadable computer software for use in management of databases featuring pharmaceutical and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing news of general interest related to disease awareness or pharmaceutical products; computer software for accessing data and information related to healthcare services and patient medical information, and for controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information |
| GS0091 | Computer software for providing, analyzing and generating reports; computer software for data processing; software and computer programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; software and computer programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analyzing data in the fields of public health, healthcare, namely pharmaceutical commercialization, biomedical research and software for analyzing clinical trial data; downloadable computer software for use in management of databases featuring pharmaceutical and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing news of general interest related to disease awareness or pharmaceutical products; computer software for accessing data and information related to healthcare services and patient medical information, and for controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-03-28 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2019-03-29 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-04-01 | 3 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2019-04-01 | 4 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2019-04-05 | 5 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2019-04-09 | 6 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-04-10 | 7 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2019-05-02 | 8 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-05-02 | 9 RFCS P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2019-05-17 | 10 NREP P: |
| REFUSAL PROCESSED BY IB | 2019-05-18 | 11 RFNP P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-10-09 | 12 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-10-09 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-10-09 | 14 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2019-11-09 | 15 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2019-11-09 | 16 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2019-11-09 | 17 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2020-03-02 | 18 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-03-02 | 19 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-03-03 | 20 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-03-05 | 21 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2020-03-11 | 22 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-03-25 | 23 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2020-03-25 | 24 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-03-25 | 25 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2020-04-10 | 26 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2020-04-14 | 27 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-04-14 | 28 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-06-30 | 29 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-09-30 | 30 FICR P: |
| FINAL DISPOSITION PROCESSED | 2020-10-20 | 31 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2020-10-20 | 32 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-11-08 | 33 FINO P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ALYVANT 79263445 not registered Live/Pending |
Roivant Sciences GmbH 2018-10-12 |
 ALYVANT 79255282 not registered Live/Pending |
Roivant Sciences GmbH 2018-07-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 